John Herzfeld v. Teva Pharmaceuticals USA, Inc.

CourtDistrict Court, C.D. California
DecidedApril 14, 2020
Docket2:18-cv-09784
StatusUnknown

This text of John Herzfeld v. Teva Pharmaceuticals USA, Inc. (John Herzfeld v. Teva Pharmaceuticals USA, Inc.) is published on Counsel Stack Legal Research, covering District Court, C.D. California primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
John Herzfeld v. Teva Pharmaceuticals USA, Inc., (C.D. Cal. 2020).

Opinion

O 11

44 55 66 77 88 United States District Court 99 Central District of California

1111 JOHN HERZFELD, Case No. 2:18-cv-09784-ODW (SSx)

1122 Plaintiff, ORDER DENYING PLAINTIFF’S MOTION FOR 1133 v. RECONSIDERATION [65]

1144 TEVA PHARMACEUTICALS USA, INC. OMNIBUS WELFARE PLAN, et al. 1155 Defendants. 1166 1177 I. INTRODUCTION 1188 Presently before the Court is Plaintiff John Herzfeld’s Motion for 1199 Reconsideration of the Court’s Order granting Defendant MCMC, LLC’s motion to 2200 dismiss (“Motion”). (Mot. for Recons. (“Mot.”), ECF No. 65.) For the reasons that 2211 follow, Plaintiff’s Motion is DENIED.1 2222 II. BACKGROUND 2233 The Court addressed the relevant factual allegations and procedural history in 2244 its Order granting Defendant MCMC’s motion to dismiss and incorporates that 2255 discussion here by reference. (See Order Granting MCMC’s Mot. to Dismiss 2266 (“Order”), ECF No. 34.) The following brief summary is provided for context. 2277

2288 1 After considering the papers filed in connection with this Motion, the Court deemed this matter appropriate for decision without oral argument. Fed. R. Civ. P. 78(b); C.D. Cal. L.R. 7-15. 1 John Herzfeld (“Herzfeld”) is a dependent of Jeffrey Herzfeld, who was 2 employed by Teva Pharmaceuticals USA, Inc. (Compl. ¶¶ 2, 8, ECF No. 1.) Teva 3 Pharmaceuticals, Inc. is the Plan Sponsor and Plan Administrator of the Teva 4 Pharmaceuticals USA, Inc. Omnibus Welfare Benefit Plan (the “Plan”), an ERISA- 5 governed welfare benefit plan. (Compl. ¶ 9.) Herzfeld was diagnosed with Duchenne 6 Muscular Dystrophy (“DMD”) at the age of six and was eighteen years old at the 7 commencement of this lawsuit. (Compl. ¶ 14.) DMD has caused Herzfeld 8 “degeneration and weakness in his muscles such that he requires a wheelchair for 9 mobility and effectively has no use of his arms without assistance.” (Compl. ¶ 4.) 10 At his doctors’ recommendation, Herzfeld requested coverage for a 11 myo-electric elbow-wrist orthoses (“EWO”) called the MyoPro. (Compl. ¶¶ 22–27, 12 57–60.) Herzfeld alleges EWOs have gained widespread acceptance in the medical 13 community, but the claims administrator (“Quantum”) denied Herzfeld’s request for 14 coverage, finding the MyoPro to be “Experimental and/or Investigational.” (Compl. 15 ¶¶ 10, 32, 44, 61.) Quantum also denied Herzfeld’s internal appeals, granted his 16 request for an external review, and assigned independent review organization (“IRO”) 17 MCMC to conduct the de novo external review. (Compl. ¶¶ 67, 72, 74–75.) With 18 some exceptions delineated in the applicable regulations, an external review is final 19 and binding. (See Compl. ¶ 56.) MCMC upheld Quantum’s coverage denial on the 20 ground that the MyoPro was “experimental and investigational.” (Compl. ¶ 76.) 21 Herzfeld initiated this action against MCMC and several other defendants. (See 22 Compl. ¶¶ 9–13.) Herzfeld asserts three causes of action under ERISA against all 23 defendants: (1) denial of benefits under 29 U.S.C. § 1132(a)(1)(B), (2) violation of 24 fiduciary duties under § 1132(a)(3), and (3) denial of full and fair review under 25 § 1133. (Compl. ¶¶ 94–115.) On August 26, 2019, the Court granted MCMC’s 26 motion to dismiss without leave to amend. (Order 11.) The Court found that MCMC 27 was not a proper defendant for any of Herzfeld’s claims because: (1) MCMC had no 28 control over administration of benefits under the Plan; (2) MCMC was not an ERISA 1 fiduciary; and (3) MCMC was not the Plan, the only proper defendant for a claim 2 under § 1133. (Order 6, 10, 11.) At MCMC’s request, the Court entered partial 3 Judgment for MCMC. (J., ECF No. 54.) 4 Herzfeld moves for reconsideration of the Court’s Order dismissing MCMC 5 under Federal Rules of Civil Procedure (“Rule”) 59(e) and 60(b), and Local Rule 6 7-18. (Mot. 7–8.) 7 III. LEGAL STANDARD 8 “[A] motion for reconsideration [under Rule 59(e)] should not be granted, 9 absent highly unusual circumstances, unless the district court is presented with newly 10 discovered evidence, committed clear error, or if there is an intervening change in the 11 controlling law.” Carroll v. Nakatani, 342 F.3d 934, 945 (9th Cir. 2003). A court 12 may disregard “repeated legal arguments” and “facts that were available earlier in the 13 proceedings.” Zimmerman v. City of Oakland, 255 F.3d 734, 740 (9th Cir. 2001). 14 Rule 60(b) provides for reconsideration of a final judgment, order, or proceeding only 15 upon a showing of (1) mistake, inadvertence, surprise, or excusable neglect; (2) newly 16 discovered evidence; (3) fraud; (4) a void judgment; (5) a satisfied judgment; or 17 (6) another reason that justifies relief. Fed. R. Civ. P. 60(b). 18 Local Rule 7-18 places additional limitations on motions for reconsideration. 19 Similar to the Federal Rules, “[n]o motion for reconsideration shall in any manner 20 repeat any oral or written argument made in support of or in opposition to the original 21 motion.” C.D. Cal. Civ. L.R. 7-18; Rosenfeld v. U.S. Dep’t of Justice, 57 F.3d 803, 22 811 (9th Cir. 1995). Grounds for a motion for reconsideration are limited to: 23 (a) a material difference in fact or law from that presented to the Court before such decision that in the exercise of reasonable diligence 24 could not have been known to the party moving for reconsideration at 25 the time of such decision, or 26 (b) the emergence of new material facts or a change of law occurring after the time of such decision, or 27 (c) a manifest showing of a failure to consider material facts 28 presented to the Court before such decision. 1 C.D. Cal. L.R. 7-18; see In re Countrywide Fin. Corp. Mortg.-Backed Sec. Litig., 966 2 F. Supp. 2d 1031, 1036 (C.D. Cal. 2013). Displeasure with the outcome alone is 3 insufficient; unless the moving party shows that one of the factors exists, the Court 4 will not grant reconsideration. See Carroll, 342 F.3d at 945 (“[A] motion for 5 reconsideration should not be granted, absent highly unusual circumstances,” unless 6 one of the factors is present); Arteaga v. Asset Acceptance, LLC, 733 F. Supp. 2d 7 1218, 1236 (E.D. Cal. 2010) (noting that mere disagreement with court’s conclusions 8 is not sufficient). 9 Reconsideration is an “extraordinary remedy, to be used sparingly in the 10 interests of finality and conservation of judicial resources.” Carroll, 342 F.3d at 945; 11 Collins v. U.S. Citizenship & Naturalization Serv., No. CV 11-9909-JFW (SSx), 2013 12 WL 776244, at *1 (C.D. Cal. Feb. 6, 2013) (internal quotation marks omitted) 13 (“Motions for reconsideration are disfavored and are rarely granted.”). Whether to 14 grant a motion for reconsideration is within the court’s discretion. McDowell v. 15 Calderon, 197 F.3d 1253, 1255 n.1 (9th Cir. 1999); Arteaga, 733 F. Supp. 2d at 1236. 16 IV. DISCUSSION 17 Herzfeld contends that a recent ruling in the Northern District of California 18 requires the Court to reconsider its finding that MCMC is not an ERISA fiduciary. 19 (Mot. 3.) Herzfeld also argues that the Court failed to consider material facts and 20 erred in its application of law. (Mot.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Ahanchian v. Xenon Pictures, Inc.
624 F.3d 1253 (Ninth Circuit, 2010)
Jesus Briones v. Riviera Hotel & Casino
116 F.3d 379 (Ninth Circuit, 1997)
Charles E. McDowell Jr. v. Arthur Calderon, Warden
197 F.3d 1253 (Ninth Circuit, 1999)
Jacqlyn Smith v. Clark County School District
727 F.3d 950 (Ninth Circuit, 2013)
Pegasus Satellite Television, Inc. v. DirecTV, Inc.
318 F. Supp. 2d 968 (C.D. California, 2004)
Sataki v. Broadcasting Board of Governors
733 F. Supp. 2d 1 (District of Columbia, 2010)
Zimmerman v. City of Oakland
255 F.3d 734 (Ninth Circuit, 2001)
Sprewell v. Golden State Warriors
266 F.3d 979 (Ninth Circuit, 2001)
Del Prete v. Magellan Behavioral Health, Inc.
112 F. Supp. 3d 942 (N.D. California, 2015)
Carroll v. Nakatani
342 F.3d 934 (Ninth Circuit, 2003)

Cite This Page — Counsel Stack

Bluebook (online)
John Herzfeld v. Teva Pharmaceuticals USA, Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/john-herzfeld-v-teva-pharmaceuticals-usa-inc-cacd-2020.